Napredna pretraga

Pregled bibliografske jedinice broj: 1006070

European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)


(EFLM WG-PRE) Cadamuro, Janne; Lippi, Giuseppe; von Meyer, Alexander; Ibarz, Mercedes; van Dongen, Edmee; Cornes, Michael; Nybo, Mads; Vermeersch, Pieter; Grankvist, Kjell; Guimaraes, Joao Tiago et al.
European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE) // Biochemia Medica, 29 (2019), 2; 020705, 12 doi:10.11613/bm.2019.020705 (međunarodna recenzija, članak, znanstveni)


Naslov
European survey on preanalytical sample handling – Part 2: Practices of European laboratories on monitoring and processing haemolytic, icteric and lipemic samples. On behalf of the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) Working Group for the Preanalytical Phase (WG-PRE)

Autori
Cadamuro, Janne ; Lippi, Giuseppe ; von Meyer, Alexander ; Ibarz, Mercedes ; van Dongen, Edmee ; Cornes, Michael ; Nybo, Mads ; Vermeersch, Pieter ; Grankvist, Kjell ; Guimaraes, Joao Tiago ; Kristensen, Gunn B.B. ; de la Salle, Barbara ; Simundic, Ana-Maria

Kolaboracija
EFLM WG-PRE

Izvornik
Biochemia Medica (1330-0962) 29 (2019), 2; 020705, 12

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Preanalytics ; standardization ; survey

Sažetak
Introduction No guideline currently exists on how to detect or document haemolysis, icterus or lipemia (HIL) in blood samples, nor on subsequent use of this information. The EFLM WG-PRE has performed a survey for assessing current practices of European laboratories in HIL monitoring. This second part of two coherent articles is focused on HIL. Materials and methods An online survey, containing 39 questions on preanalytical issues, was disseminated among EFLM member countries. Seventeen questions exclusively focused on assessment, management and follow-up actions of HIL in routine blood samples. Results Overall, 1405 valid responses from 37 countries were received. A total of 1160 (86%) of all responders stating to analyse blood samples - monitored HIL. HIL was mostly checked in clinical chemistry samples and less frequently in those received for coagulation, therapeutic drug monitoring and serology/infectious disease testing. HIL detection by automatic HIL indices or visual inspection, along with haemolysis cut- offs definition, varied widely among responders. A quarter of responders performing automated HIL checks used internal quality controls. In haemolytic/icteric/lipemic samples, most responders (70%) only rejected HIL-sensitive parameters, whilst about 20% released all test results with general comments. Other responders did not analysed but rejected the entire sample, while some released all tests, without comments. Overall, 26% responders who monitored HIL were using this information for monitoring phlebotomy or sample transport quality. Conclusion Strategies for monitoring and treating haemolytic, icteric or lipemic samples are quite heterogeneous in Europe. The WG-PRE will use these insights for developing and providing recommendations aimed at harmonizing strategies across Europe.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Ustanove
Klinička bolnica "Sveti Duh"

Autor s matičnim brojem:
Ana-Maria Šimundić, (235703)

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE


Citati